PLABiologics develops placenta-based therapeutic treatments to reverse degenerative diseases, harnessing regenerative properties for tissue repair and immunomodulation.

Vision and Mission: To bring fundamental happiness to humanity from birth to better aging through innovative placenta-based therapeutics.

Noteworthy Points:

• Founded in 2022, focusing on reversing degenerative diseases.
• Holds a robust pipeline of first-in-class drugs.
• Published significant research in the field of protein science.